围手术期免疫营养对头颈癌或胃肠癌手术患者术后结局的影响:随机对照试验的系统评价与Meta分析
该系统评价与Meta分析纳入48项随机对照试验、共4825例接受头颈癌或胃肠癌择期手术的成人患者,比较围手术期免疫营养与标准营养治疗。免疫营养降低了总术后并发症(相对危险度0.78,95%CI 0.66-0.93,证据确定性高)和感染性并发症(相对危险度0.71,95%CI 0.61-0.82,证据确定性高)。
要点
- 纳入48项随机对照试验共4825例头颈癌或胃肠癌手术患者。
- 免疫营养组总术后并发症相对危险度0.78(95%CI 0.66-0.93),证据确定性高。
- 免疫营养组感染性并发症相对危险度0.71(95%CI 0.61-0.82),证据确定性高。
核心结论
- 对头颈癌和胃肠癌患者,围手术期免疫营养干预可显著降低总术后并发症和感染性并发症。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE(PubMed)、MEDLINE(OVID)、EMBASE、Cochrane对照试验中心注册库、Web of Science核心合集和Emcare,检索年限为1981年至2022年。
- 纳入随机对照试验;干预为围手术期含精氨酸、n-3欧米伽脂肪酸或谷氨酰胺的免疫营养治疗,对照为标准营养治疗。
- 共纳入48项研究、4825例患者,其中上消化道癌19项、下消化道癌9项、混合癌8项、头颈癌12项。
- 主要结局为术后30天内发生的Clavien-Dindo分级≥II级的总术后并发症和感染性并发症。
主要发现
- 与标准营养治疗相比,免疫营养降低总术后并发症(相对危险度0.78;95%CI 0.66-0.93;证据确定性高)。
- 与标准营养治疗相比,免疫营养降低感染性并发症(相对危险度0.71;95%CI 0.61-0.82;证据确定性高)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To clarify whether perioperative immunonutrition is effective in adult patients with or without malnutrition undergoing elective surgery for head and neck (HAN) or gastrointestinal (GI) cancers. BACKGROUND: It is important to avoid postoperative complications in patients with cancer as they can compromise clinical outcomes. There is no consensus on the efficacy of perioperative immunonutrition in patients with or without malnutrition undergoing HAN or GI cancer surgery. MATERIALS AND METHODS: We searched MEDLINE (PubMed), MEDLINE (OVID), EMBASE, Cochrane Central Register of Controlled Trials, Web of Science Core Selection, and Emcare from 1981 to 2022 using search terms related to immunonutrition and HAN or GI cancer. We included randomized controlled trials. Intervention was defined as immunonutritional therapy including arginine, n-3 omega fatty acids, or glutamine during the perioperative period. The control was defined as standard nutritional therapy. The primary outcomes were total postoperative and infectious complications, defined as events with a Clavien-Dindo classification grade ≥ II that occurred within 30 days after surgery. RESULTS: Of the 4825 patients from 48 included studies, 19 had upper GI cancer, 9 had lower, and 8 had mixed cancer, whereas 12 had HAN cancers. Immunonutrition reduced the total postoperative complications (relative risk ratio: 0.78; 95% CI, 0.66-0.93; certainty of evidence: high) and infectious complications (relative risk ratio: 0.71; 95% CI, 0.61-0.82; certainty of evidence: high) compared with standard nutritional therapy. CONCLUSIONS: Nutritional intervention with perioperative immunonutrition in patients with HAN and GI cancers significantly reduced total postoperative complications and infectious complications.
引用
- Matsui R, Sagawa M, Sano A, et al. Impact of Perioperative Immunonutrition on Postoperative Outcomes for Patients Undergoing Head and Neck or Gastrointestinal Cancer Surgeries: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Ann Surg. 2023. PMID: 37882375. doi:10.1097/SLA.0000000000006116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。